16:04 EDT Structure Therapeutics files to sell 8M ADSs representing 24M ordinary shares
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on GPCR:
- Structure Therapeutics Reports Breakthrough in Obesity Study
- Structure Therapeutics Reports Positive Topline Data from its Phase 2a Obesity Study and Capsule to Tablet PK Study for its Oral Non-Peptide Small Molecule GLP-1 Receptor Agonist GSBR-1290
- J.P. Morgan Predicts up to 210% Gains for These 2 ‘Strong Buy’ Stocks
- Structure Therapeutics (NASDAQ:GPCR): Analysts See 130% Upside in This GLP-1 Stock
- Structure Therapeutics initiated with an Overweight at JPMorgan